KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to 0.35%.

  • Eli Lilly's Return on Invested Capital rose 700.0% to 0.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.35%, marking a year-over-year increase of 700.0%. This contributed to the annual value of 0.37% for FY2024, which is 700.0% up from last year.
  • According to the latest figures from Q3 2025, Eli Lilly's Return on Invested Capital is 0.35%, which was up 700.0% from 0.34% recorded in Q2 2025.
  • Over the past 5 years, Eli Lilly's Return on Invested Capital peaked at 0.35% during Q3 2025, and registered a low of 0.23% during Q2 2023.
  • Its 5-year average for Return on Invested Capital is 0.28%, with a median of 0.28% in 2024.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first soared by 900bps in 2022, then crashed by -1000bps in 2023.
  • Over the past 5 years, Eli Lilly's Return on Invested Capital (Quarter) stood at 0.25% in 2021, then grew by 16bps to 0.3% in 2022, then decreased by -7bps to 0.27% in 2023, then increased by 12bps to 0.31% in 2024, then grew by 13bps to 0.35% in 2025.
  • Its Return on Invested Capital was 0.35% in Q3 2025, compared to 0.34% in Q2 2025 and 0.32% in Q1 2025.